亚太地区地尔硫卓市场预测至 2028 年 - COVID-19 影响和按产品类型（胶囊、注射剂和片剂）和应用（心绞痛、高血压等）进行的区域分析
No. of Pages: 109 | Report Code: TIPRE00025367 | Category: Life Sciences
No. of Pages: 109 | Report Code: TIPRE00025367 | Category: Life Sciences
地尔硫卓是一种苯并硫氮杂卓衍生物起到抗高血压和血管扩张剂的作用。地尔硫卓是一种抗高血压和血管扩张剂，通过放松血管肌肉来降低血压。这是由于降低血压具有长期治疗作用，因为它降低了致命和非致命心血管事件（如中风和心肌梗塞）的风险。根据体外结合实验，地尔硫卓与血浆蛋白的结合率为70%-80%。在临床相关浓度下，大约 40% 的药物被认为与 α-1-糖蛋白结合，而大约 30% 的药物被认为与白蛋白结合。
亚太地区地尔硫卓市场预计将达到到 2028 年，将从 2021 年的 6,784 万美元增至 1.6034 亿美元；预计 2021 年至 2028 年复合年增长率为 13.1%。政府推广举措的增加、心血管疾病 (CVD) 患病率的增加以及全球患有心脏病的老年人口的增加预计将推动该市场的发展多年来的增长。然而，地尔硫卓对消费的副作用可能会对未来几年的市场增长产生负面影响。
全世界心血管疾病的患病率正在上升，特别是在发展中国家国家。在这些国家，现代化的设施减少了人们的体力活动。此外，人们的压力水平也在增加。由于采用现代化设施而导致生活方式的改变和其他健康状况的改变，发展中国家的心血管疾病发病率正在上升，这推动了对地尔硫卓的需求。发展中国家正在大力发展其医疗保健设施和服务，并正在迈向技术进步。例如，亚太等地区的结构心脏正处于发展初期。 2021 年 3 月，Glenmark Pharma 的盐酸地尔硫卓胶囊获得了美国 FDA 的最终批准。 Glenmark Pharmaceuticals 的盐酸地尔硫卓缓释胶囊 USP（60 毫克、90 毫克和 120 毫克）已获得竞争性仿制药 (CGT) 称号。获得批准后，该公司成为此类竞争性仿制药疗法的首家获批申请人，并有资格在商业上市后获得 180 天的 CGT 独占权。此外，Glenmark 正在扩大其在瑞士和其他发展中国家的足迹。因此，市场参与者以高性价比产品进入市场的机会更大。因此，上述因素将为预测期内地尔硫卓市场的增长创造有利可图的机会。此外，地尔硫卓市场的特点是亚太地区各种大大小小的公司。市场参与者采取新产品推出、区域扩张和产品批准等策略来增加市场份额。参与者正在投资研发以开发先进技术并获得可观的收入份额。因此，近期的发展预计将成为地尔硫卓市场的未来趋势。
COVID-19 大流行已广泛影响亚太地区的经济。此次疫情影响了全球经济的三个主要方面——生产、供应链、企业和金融市场。供应链中断以及对新型冠状病毒肺炎 (COVID-19) 有效治疗方法的巨大需求，使亚太地区的医疗保健研究行业处于至关重要的境地。已采取禁止性措施来控制这一流行病的蔓延。近年来，日本高血压和肥胖患者不断增加，感染COVID-19的风险异常高，因此需要仔细观察和强化治疗。但值得注意的是，钙通道阻滞剂对抗COVID-19的治疗机制仍有待进一步研究和随机对照临床试验。这种情况对亚太地区的地尔硫卓市场产生积极影响。
根据产品，亚太地区地尔硫卓市场分为胶囊剂、注射剂和片剂。 2021年，平板电脑细分市场占据最大市场份额。然而，预计2021年至2028年胶囊细分市场的复合年增长率最快。
根据应用，亚太地尔硫卓市场分为心绞痛、高血压等。 2021年，高血压细分市场占据最大市场份额。预计未来几年心绞痛细分市场将以最快的复合年增长率增长。
与本亚太地尔硫卓市场报告相关的一些主要和二手来源是国家生物技术信息中心 (NCBI)、中国国家老龄化委员会 (CNCA) 和全印度医学科学研究所 (AIIMS) 等。
Strategic insights for Asia Pacific Diltiazem involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 67.84 Million |
| Market Size by 2028 | US$ 160.34 Million |
| Global CAGR (2021 - 2028) | 13.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Diltiazem refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Diltiazem Market is valued at US$ 67.84 Million in 2021, it is projected to reach US$ 160.34 Million by 2028.
As per our report Asia Pacific Diltiazem Market, the market size is valued at US$ 67.84 Million in 2021, projecting it to reach US$ 160.34 Million by 2028. This translates to a CAGR of approximately 13.1% during the forecast period.
The Asia Pacific Diltiazem Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Diltiazem Market report:
The Asia Pacific Diltiazem Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Diltiazem Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Diltiazem Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Diltiazem Market
